Atle Fund Management AB Diversified Active

Location: Stockholm, Sweden

CIK: 0001381843 · Show all filings

Period: Q3 2024 (← Previous) (Next →)

Filing Date: Nov 12, 2024

Total Value: $213M (100.0% shares, 0.0% debt)

Holdings (36)

LLY ELI LILLY & CO 12.7%
Value $27.08M Shares 30,564 Est. Cost $673.54 Unrealized +32.2%
UNH UNITEDHEALTH GROUP INC 9.8%
Value $20.75M Shares 35,490 Est. Cost $502.95 Unrealized +9.0%
MRK MERCK & CO INC 8.3%
Value $17.57M Shares 154,699 Est. Cost $108.20 Unrealized +4.4%
TMO THERMO FISHER SCIENTIFIC INC 6.4%
Value $13.62M Shares 22,012 Est. Cost $524.23 Unrealized +12.4%
AMGN AMGEN INC 4.4%
Value $9.333M Shares 28,965 Est. Cost $267.21 Unrealized +17.2%
BSX BOSTON SCIENTIFIC CORP 4.2%
Value $8.897M Shares 106,172 Est. Cost $59.99 Unrealized +31.4%
ABBV ABBVIE INC 4.1%
Value $8.785M Shares 44,486 Est. Cost $152.15 Unrealized +17.4%
SYK STRYKER CORPORATION 4.0%
Value $8.475M Shares 23,460 Est. Cost $301.71 Unrealized +12.8%
COR CENCORA INC 3.9%
Value $8.225M Shares 36,544 Est. Cost $208.00 Unrealized +10.4%
VRTX VERTEX PHARMACEUTICALS INC 3.7%
Value $7.903M Shares 16,993 Est. Cost $402.23 Unrealized +19.4%
REGN REGENERON PHARMACEUTICALS 3.5%
Value $7.388M Shares 7,028 Est. Cost $879.81 Unrealized +25.8%
NBIX NEUROCRINE BIOSCIENCES INC 3.3%
Value $6.983M Shares 60,607 Est. Cost $134.46 Unrealized +2.0%
ALKS ALKERMES PLC 3.1%
Value $6.623M Shares 236,610 Est. Cost $26.04 Unrealized +2.4%
INTRA-CELLULAR THERAPIES INC 2.9%
Value $6.189M Shares 84,578 Est. Cost $71.76 Unrealized
HRMY HARMONY BIOSCIENCES HLDGS IN 2.9%
Value $6.075M Shares 151,875 Est. Cost $33.61 Unrealized +4.5%
UFPT UFP TECHNOLOGIES INC 2.7%
Value $5.716M Shares 18,048 Est. Cost $279.83 Unrealized +13.9%
MIRM MIRUM PHARMACEUTICALS INC 2.5%
Value $5.395M Shares 138,321 Est. Cost $33.15 Unrealized +20.3%
DXCM DEXCOM INC 1.7%
Value $3.604M Shares 53,757 Est. Cost $102.32 Unrealized -19.7%
ACLX ARCELLX INC 1.6%
Value $3.36M Shares 40,230 Est. Cost $58.42 Unrealized +14.0%
IONS IONIS PHARMACEUTICALS INC 1.6%
Value $3.313M Shares 82,691 Est. Cost $47.13 Unrealized -1.3%
CAH CARDINAL HEALTH INC 1.4%
Value $3.039M Shares 27,500 Est. Cost $62.95 Unrealized +62.6%
FOLD AMICUS THERAPEUTICS INC 1.4%
Value $2.942M Shares 275,472 Est. Cost $11.76 Unrealized -7.4%
MERUS N V 1.2%
Value $2.532M Shares 50,687 Est. Cost $40.30 Unrealized
EW EDWARDS LIFESCIENCES CORP 1.1%
Value $2.409M Shares 36,505 Est. Cost $77.31 Unrealized -6.0%
NAMS NEWAMSTERDAM PHARMA COMPANY 1.1%
Value $2.307M Shares 138,983 Est. Cost $18.84 Unrealized -8.2%
SMMT SUMMIT THERAPEUTICS INC 0.9%
Value $1.884M Shares 86,013 Est. Cost $13.98 Unrealized 0.0%
IMCR IMMUNOCORE HLDGS PLC 0.8%
Value $1.683M Shares 54,060 Est. Cost $46.31 Unrealized
KRYS KRYSTAL BIOTECH INC 0.8%
Value $1.675M Shares 9,202 Est. Cost $130.58 Unrealized +47.7%
AUTL AUTOLUS THERAPEUTICS PLC 0.8%
Value $1.606M Shares 442,423 Est. Cost $4.20 Unrealized
CRBP CORBUS PHARMACEUTICALS HLDGS 0.7%
Value $1.435M Shares 69,573 Est. Cost $36.55 Unrealized +40.0%
BBIO BRIDGEBIO PHARMA INC 0.6%
Value $1.36M Shares 53,432 Est. Cost $29.94 Unrealized -12.3%
SLNO SOLENO THERAPEUTICS INC 0.6%
Value $1.332M Shares 26,390 Est. Cost $47.87 Unrealized 0.0%
MERSANA THERAPEUTICS INC 0.5%
Value $1.018M Shares 538,621 Est. Cost $2.39 Unrealized
MREO MEREO BIOPHARMA GROUP PLC 0.4%
Value $822K Shares 200,000 Est. Cost $4.11 Unrealized
CABA CABALETTA BIO INC 0.4%
Value $795K Shares 168,522 Est. Cost $11.29 Unrealized -48.7%
PHVS PHARVARIS N V 0.3%
Value $636K Shares 34,328 Est. Cost $20.35 Unrealized -10.2%